DavidGerberMD

PubMed

• 8 citations
  Survival of women diagnosed with breast cancer and who have survived a previous cancer
  Sandi L. Pruitt, Hong Zhu, Daniel F. Heitjan, Asal Rahimi, Bhumika Maddineni, Anna Tavakkoli, Ethan A. Halm, David E. Gerber, Danyi Xiong, Caitlin C. Murphy> ;Breast Cancer Research and Treatment. 2021 Feb 23
• 14 citations
  Modernizing clinical trial eligibility criteria: Recommendations of the ASCO-friends of cancer research laboratory reference ranges and testing intervals work group
  Alexander I. Spira, Mark Stewart, Suzanne F. Jones, Elaine Chang, Anitra Fielding, Nicole Richie, Laura S. Wood, Michael A. Thompson, Lee W. Jones, Abhilasha Nair, Bra...> ;Clinical Cancer Research. 2021 May 1
• 1 citations
  Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual.
  Simon J. Craddock Lee, Caitlin C. Murphy, David E. Gerber, Ann M. Geiger, Ethan A. Halm, Rasmi G Nair, John Cox, Jasmin A. Tiro, Celette Sugg Skinner> ;Medical Care. 2021 Jan 22
• 251 citations
  Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
  Hossein Borghaei, Scott N. Gettinger, Everett E. Vokes, Laura Q.M. Chow, Marco Angelo Burgio, Javier de Castro Carpeño, Adam Pluzanski, Oscar Arrieta, Osvaldo Arén Fro...> ;Journal of Clinical Oncology. 2021 Jan 15
• 5 citations
  Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
  Sawsan Rashdan, Hui Yang, Tri Le, Christopher Selby, David E. Gerber, Carlos A. Alvarez> ;Clinical Drug Investigation. 2021 Jan 8
• 20 citations
  Preliminary Clinical and Molecular Analysis Results From a Single-Arm Phase 2 Trial of Brigatinib in Patients With Disease Progression After Next-Generation ALK Tyrosi...
  Thomas E. Stinchcombe, Robert C. Doebele, Xiaofei Wang, David E. Gerber, Leora Horn, D. Ross Camidge> ;Journal of Thoracic Oncology. 2021 Jan 1
• 6 citations
  Clinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical System.
  David E. Gerber, Heidi A. Hamann, Olivia Dorsey, Chul Ahn, Jessica L. Phillips, Noel O. Santini, Travis Browning, Cristhiaan D. Ochoa, Joyce Adesina, Vijaya Subbu Natc...> ;Clinical Lung Cancer. 2021 Jul 1
• 12 citations
  Immunotherapy Use in Patients With Lung Cancer and Comorbidities.
  Mitchell S. von Itzstein, Helen G. Mayo, John D. Minna, David E. Gerber> ;Cancer Journal. 2020 Nov 1
• 17 citations
  Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments.
  David E. Gerber, Thomas Sheffield, M. Shaalan Beg, Erin L Williams, Valerie L Clark, Yang Xie, M. E. Blair Holbein, Celette Sugg Skinner, Simon J. Craddock Lee> ;Journal of the National Comprehensive Cancer Network. 2021 May 1
• Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients
  Mitchell S. von Itzstein, David E. Gerber, John D. Minna> ;Ebiomedicine. 2020 Sep 22
• 52 citations
  DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden.
  David Hsiehchen, Antony Hsieh, Robert M. Samstein, Tianshi Lu, Muhammad Shaalan Beg, David E. Gerber, Tao Wang, Luc G. T. Morris, Hao Zhu> ;Cell Reports. Medicine. 2020 Jun 23
• 5 citations
  Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (N...
  Jyoti D. Patel, Ju Whei Lee, David P. Carbone, Henry N. Wagner, Anil Shanker, Maria Teresa P. de Aquino, Leora Horn, Melissa Lynne Johnson, David E. Gerber, Jane Jijun...> ;Clinical Lung Cancer. 2020 Jun 12
• 47 citations
  EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer
  Ke Gong, Gao Guo, Nishah Panchani, Matthew E. Bender, David E. Gerber, John D. Minna, Farjana J. Fattah, Boning Gao, Michael Peyton, Kemp H. Kernstine, Bipasha Mukherj...> ;Nature Cancer. 2020 Apr 6
• 17 citations
  Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.
  Ruth Sacks, Jennie Y Law, Hong Zhu, Muhammad Shaalan Beg, David E. Gerber, Baran D. Sumer, Larry L. Myers, John M. Truelson, Lucien A. Nedzi, David J. Sher, Randall S....> ;Oncology. 2020 Jan 1
• 20 citations
  Conceptual Model for Accrual to Cancer Clinical Trials
  Simon J. Craddock Lee, Caitlin C. Murphy, Ann M. Geiger, David E. Gerber, John Cox, Rasmi G Nair, Celette Sugg Skinner> ;Journal of Clinical Oncology. 2019 Jun 5
• 13 citations
  Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice
  Sawsan Rashdan, David E. Gerber> ;Translational Lung Cancer Research. 2019 Jun 1
• 10 citations
  Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.
  Tao Wang, Rong Lu, Sunny Lai, Joan H. Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E. Gerber, David H. Johnson, Guanghua Xiao, Yang Xie> ;Cancer Informatics. 2019 Apr 5
• 26 citations
  Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published Cases.
  Elizabeth McGehee, David E. Gerber, Joan S. Reisch, Jonathan E. Dowell> ;Clinical Lung Cancer. 2019 Mar 1
• 16 citations
  Hyperprogressive disease: a distinct effect of immunotherapy?
  Vinita Popat, David E. Gerber> ;Journal of Thoracic Disease. 2019 Mar 1
• 27 citations
  Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer.
  David E. Gerber, Leora Horn, M. Boyer, Rachel E. Sanborn, Ronald B. Natale, Ramon Palmero, P. Bidoli, Igor Bondarenko, Paul Germonpré, D. Ghizdavescu, Athanasios Kotsa...> ;Annals of Oncology. 2018 Jul 1
• Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients
  Yang Xie, Matthew Maclean, David E Gerber> ;Journal of Thoracic Oncology.
• 31 citations
  Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
  Osama Mohamad, Alberto Diaz de Leon, Samuel R. Schroeder, Andrew Leiker, Alana Christie, E.R. Zhang-Velten, Lakshya U. Trivedi, Saad A. Khan, Neil Desai, Aaron Laine, ...> ;Oncoimmunology. 2018 Mar 15
• Characteristics of Patients Using Patient Portals in Oncology.
  Pho, K.,Lu, R.,Gates, S.,Xie, Y.,Lee, SJC.,Gerber, D. E.> ;JAMA Oncol. 2018 Jan 27
• 3 citations
  Institutional Scientific Review of Cancer Clinical Research Protocols: A Unique Requirement That Affects Activation Timelines.
  Ning, N., Yan, J., Dietrich, M. F., Xie, X. J., Gerber, D. E.> ;Journal of oncology practice. 2017 Oct 12
• Cancer Center Clinic and Research Team Perceptions of Identity and Interactions.
  Reimer, T.,Lee, SJC.,Garcia, S.,Gill, M.,Duncan, T.,Williams, E. L.,Gerber, D. E.> ;J Oncol Pract. 2017 Oct 14
• Join now to see all